Head and neck cancers are among the most difficult to treat. They can be aggressive and are located near some of the body's ...

Talking to loved ones about a recent head and neck cancer diagnosis can be overwhelming. Of course, there is no one "right" ...

Vietnam Head and Neck Cancer Diagnostics Market Key Takeaways: The Vietnam head and neck cancer diagnostics market are witnessing significant growth attributed to several factors. The increasing ...

Results from the Phase III KEYNOTE-689 trial show that adding perioperative Keytruda (pembrolizumab) to standard-of-care radiotherapy improves event-free survival in patients with resectable, locally ...

Proper nutrition is important for people diagnosed with cancer, both to help them feel better and to assist them in ...

Neoadjuvant and adjuvant pembrolizumab added to standard care significantly improves event-free survival in HNSCC.

Head and neck cancer arises in the mucosal epithelium, most often in the oral cavity, followed by the larynx and pharynx.

Head and neck cancer is the sixth most common cancer in the world, with almost two-thirds of patients diagnosed when they have locally advanced disease.

Head and neck cancers, encompassing growths in the throat, larynx, nose, and mouth, account for 4% of cancers worldwide. Key risk factors include tobacco and alcohol use, HPV infection, and poor oral ...

TIGIT-targeting therapies have largely disappointed in recent months, with failed studies, terminated partnerships and ...

It is characterized by a progressive depletion of skeletal muscle and fat, resulting in profound weakness. Unlike ...

EXEL surges 35.2% in three months as strong Cabometyx sales and zanzalintinib trial success fuel investor optimism.